Patent ID: 11944612
Assignee: GLOBAL BLOOD THERAPEUTICS, INC.
Field: Pharmaceuticals (Chemistry)
Classification: CPC A | IPC A

Claim 7:
8. The capsule dosage form of claim 6 wherein:
the compound 1 is in a crystalline ansolvate form characterized by at least four X-ray powder diffraction peaks (Cu Kα radiation) at 13.37°, 14.37°, 19.950 and 23.92° 2θ, each peak is ±0.2° 2θ,
the binder is hypromellose;
the insoluble filler is microcrystalline cellulose;
the soluble filler is lactose monohydrate;
the disintregrant is croscarmellose sodium; and
the lubricant is magnesium stearate.